外科减重手术与药物治疗2型糖尿病伴肥胖患者的药物经济学评价

杨婷; 卞晓洁; 褚薛慧; 孙喜太<sup>*</sup>; 葛卫红<sup>*</sup>

引用本文:	杨婷,卞晓洁,褚薛慧,孙喜太,葛卫红.外科减重手术与药物治疗2型糖尿病伴肥胖患者的药物经济学评价[J].中国现代应用药学,2018,35(5):725-729.
	YANG Ting,BIAN Xiaojie,CHU Xuehui,SUN Xitai,GE Weihong.Pharmacoeconomic Evaluation of Surgical Weight Loss Surgery and Drug Therapy for Type 2 Diabetes Mellitus Accompanied with Obesity Patients[J].Chin J Mod Appl Pharm(中国现代应用药学),2018,35(5):725-729.

【打印本页】【HTML】【下载PDF全文】【查看/发表评论】【EndNote】【RefMan】【BibTex】

←前一篇|后一篇→

过刊浏览高级检索

本文已被：浏览 2004次下载 1654次	码上扫一扫！
分享到：微信更多字体:加大+\|默认\|缩小-
外科减重手术与药物治疗2型糖尿病伴肥胖患者的药物经济学评价
杨婷¹, 卞晓洁¹, 褚薛慧², 孙喜太², 葛卫红¹
1.南京鼓楼医院药学部, 南京 210008;2.南京鼓楼医院普外科, 南京 210008

摘要:

目的分析腹腔镜胃旁路减重手术和传统药物治疗2型糖尿病（type Ⅱ diabetes mellitus，T2DM）伴肥胖的经济性。方法回顾性研究南京鼓楼医院2014年6月-2016年5月因T2DM伴肥胖入院的患者76例，分成2组（A组接受腹腔镜胃旁路减重手术，B组接受药物治疗），用决策树分析2组治疗方案的成本效果。结果治疗24周，A组和B组的期望成本分别是47 353元和3 838元，成本效果比分别是485.1和40.8；治疗48周，A组和B组的期望成本分别是47 438元和6 588元，成本效果比分别是486和70。结论从成本效果分析结果来看，药物方法治疗T2DM伴肥胖比手术方法更经济。

关键词: 决策树分析 Ⅱ型糖尿病伴肥胖腹腔镜胃旁路减重手术

DOI：10.13748/j.cnki.issn1007-7693.2018.05.022

分类号:R956

基金项目:江苏省医疗保险研究会科研基金（GYH720170048）

Pharmacoeconomic Evaluation of Surgical Weight Loss Surgery and Drug Therapy for Type 2 Diabetes Mellitus Accompanied with Obesity Patients

YANG Ting¹, BIAN Xiaojie¹, CHU Xuehui², SUN Xitai², GE Weihong¹

1.Department of Pharmacy, Nanjing Drum Tower Hospital, Nanjing 210008, China;2.Department of General Surgery, Nanjing Drum Tower Hospital, Nanjing 210008, China

Abstract:

OBJECTIVE To analyze the economy of laparoscopic subtractive surgery and traditional drug therapy in the treatment of type 2 diabetes mellitus (T2DM) accompanied with obesity.METHODS A total of 76 patients with T2DM accompanied with obesity from June 2014 to May 2016 in Nanjing Drum Tower Hospital were enrolled in this study (Group A:received laparoscopic subtracted gastric bypass surgery; Group B:received drug therapy). Decision Tree was used to analyze the cost-effective of the two groups.RESULTS The expected cost of group A and group B were 47 353 and 3 838 yuan in 24 weeks respectively, the cost-effectiveness ratios were 485.1 and 40.8 respectively; the expected cost of group A and group B were 47 438 and 6 588 yuan in 48 weeks respectively, the cost-effectiveness ratios were 486 and 70.CONCLUSION From the results of cost-effectiveness analysis, drug treatment of T2DM accompanied with obesity is more economical than surgical methods.

Key words: decision tree analysis T2DM accompanied with obesity laparoscopic subtractive surgery